Literature DB >> 12468130

Andropause and quality of life: findings from patient focus groups and clinical experts.

Annoesjka Novák1, Meryl Brod, Jolanda Elbers.   

Abstract

OBJECTIVES: To develop a condition-specific quality of life (QoL) questionnaire to assess the symptoms of the decline in testosterone that occurs as men age, otherwise known as the andropause.
METHODS: Two focus groups of patients with low testosterone levels and an expert panel of physicians in the treatment of male testosterone deficiency.
RESULTS: The patient focus groups confirmed that men are unlikely to realise they have low testosterone levels until this is diagnosed and that they are unlikely to share their experiences with peers. Both patients and physicians considered decreased energy levels and impaired sexual performance had the greatest adverse impact on well-being. Patients generally felt that testosterone replacement therapy led to improved energy levels and, to a lesser extent, improved libido and erectile function. Evaluation of the responses resulted in the identification of seven key domains (energy, emotional, social, social emotional, mental functioning, physical functioning and sexual functioning) that should be considered when assessing the impact of andropause on QoL.
CONCLUSIONS: Understanding the impact of low testosterone levels on QoL is critical to diagnosis and effective treatment. The use of an andropause-specific QoL questionnaire will facilitate quantification of patient experiences and may thus improve subsequent therapy. Copyright 2002 Publidhed by Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468130     DOI: 10.1016/s0378-5122(02)00274-8

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  7 in total

1.  Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial.

Authors:  Seng-Fah Tong; Chirk-Jenn Ng; Boon-Cheok Lee; Verna-K M Lee; Ee-Ming Khoo; Eng-Giap Lee; Hui-Meng Tan
Journal:  Asian J Androl       Date:  2012-05-28       Impact factor: 3.285

Review 2.  How to recognize late-onset hypogonadism in men with sexual dysfunction.

Authors:  Giovanni Corona; Giulia Rastrelli; Linda Vignozzi; Edoardo Mannucci; Mario Maggi
Journal:  Asian J Androl       Date:  2012-01-30       Impact factor: 3.285

3.  A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy.

Authors:  Annik Prat; Maik Behrendt; Edwige Marcinkiewicz; Sebastien Boridy; Ram M Sairam; Nabil G Seidah; Dusica Maysinger
Journal:  J Aging Res       Date:  2011-09-28

4.  Diverse characteristics of the urinary excretion of amino acids in humans and the use of amino acid supplementation to reduce fatigue and sub-health in adults.

Authors:  R H Dunstan; D L Sparkes; M M Macdonald; X Janse De Jonge; B J Dascombe; J Gottfries; C-G Gottfries; T K Roberts
Journal:  Nutr J       Date:  2017-03-23       Impact factor: 3.271

5.  Knowledge and Attitude about Andropause Among General Physicians in Shiraz, Iran 2014.

Authors:  Maliheh Abootalebi; Marzieh Kargar; Iran Jahanbin; Alireza Amin Sharifi; Zahra Sharafi
Journal:  Int J Community Based Nurs Midwifery       Date:  2016-01

6.  Psychometric testing of two new patient-reported outcome instruments for the evaluation of treatment for hypogonadism.

Authors:  R P Hayes; X Ni; D E Heiselman; K Kinchen
Journal:  Int J Clin Pract       Date:  2016-06-13       Impact factor: 2.503

7.  Quality of life in Klinefelter patients on testosterone replacement therapy compared to healthy controls: an observational study on the impact of psychological distress, personality traits, and coping strategies.

Authors:  M Fabrazzo; G Accardo; I Abbondandolo; G Goglia; D Esposito; G Sampogna; F Catapano; D Giugliano; D Pasquali
Journal:  J Endocrinol Invest       Date:  2020-08-31       Impact factor: 4.256

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.